Retraction Note: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo
- PMID: 37429930
- PMCID: PMC10333264
- DOI: 10.1038/s41598-023-38389-y
Retraction Note: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo
Retraction of
-
Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.Sci Rep. 2018 Jul 13;8(1):10594. doi: 10.1038/s41598-018-28906-9. Sci Rep. 2018. Retraction in: Sci Rep. 2023 Jul 10;13(1):11162. doi: 10.1038/s41598-023-38389-y. PMID: 30006571 Free PMC article. Retracted.
Similar articles
-
Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.Sci Rep. 2018 Jul 13;8(1):10594. doi: 10.1038/s41598-018-28906-9. Sci Rep. 2018. Retraction in: Sci Rep. 2023 Jul 10;13(1):11162. doi: 10.1038/s41598-023-38389-y. PMID: 30006571 Free PMC article. Retracted.
-
Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.Oncotarget. 2015 Jun 20;6(17):15022-34. doi: 10.18632/oncotarget.3609. Oncotarget. 2015. PMID: 25909283 Free PMC article.
-
Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.BMC Cancer. 2014 Dec 12;14:938. doi: 10.1186/1471-2407-14-938. BMC Cancer. 2014. PMID: 25494879 Free PMC article.
-
Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.Oncotarget. 2017 Mar 21;8(12):18991-19012. doi: 10.18632/oncotarget.15086. Oncotarget. 2017. PMID: 28177909 Free PMC article.
-
Fibulin-5 function during tumorigenesis.Future Oncol. 2005 Feb;1(1):23-35. doi: 10.1517/14796694.1.1.23. Future Oncol. 2005. PMID: 16555973 Review.
References
Publication types
LinkOut - more resources
Full Text Sources